Cargando…
Isomangiferin, a Novel Potent Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor, Suppresses Breast Cancer Growth, Metastasis and Angiogenesis
PURPOSE: Vascular endothelial growth factor (VEGF) signal transduction mainly depends on its binding to VEGF receptor 2 (VEGFR-2). VEGF downstream signaling proteins mediate several of its effects in cancer progression, including those on tumor growth, metastasis, and blood vessel formation. The act...
Autores principales: | Wang, Banghua, Shen, Jia, Wang, Zexia, Liu, Jianxia, Ning, Zhifeng, Hu, Meichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880961/ https://www.ncbi.nlm.nih.gov/pubmed/29628979 http://dx.doi.org/10.4048/jbc.2018.21.1.11 |
Ejemplares similares
-
Isomangiferin Attenuates Renal Injury in Diabetic Mice via Inhibiting Inflammation
por: Yue, Shuwen, et al.
Publicado: (2020) -
Lycorine inhibits glioblastoma multiforme growth through EGFR suppression
por: Shen, Jia, et al.
Publicado: (2018) -
Harmine suppresses bladder tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis
por: Hai-rong, Cai, et al.
Publicado: (2019) -
Fisetin inhibits vascular endothelial growth factor-induced angiogenesis in retinoblastoma cells
por: Wang, Liangjun, et al.
Publicado: (2020) -
Luteolin Inhibits Human Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis
por: Pratheeshkumar, Poyil, et al.
Publicado: (2012)